ELAN - Elanco Animal Health Incorporated
NYSE
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Greenfield,
United States
Type: Equity
ELAN price evolution
ELAN
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $352 | $369 | $367 | $318 |
| Short term investments | ||||
| Net receivables | $1010 | $1135 | $1225 | $1264 |
| Inventory | $1735 | $1690 | $1690 | $1596 |
| Total current assets | $3407 | $3565 | $3652 | $3548 |
| Long term investments | ||||
| Property, plant & equipment | $1026 | $992 | $1007 | $1000 |
| Goodwill & intangible assets | $9588 | $9377 | $10718 | $10852 |
| Total noncurrent assets | $10955 | $10779 | $12144 | $12221 |
| Total investments | ||||
| Total assets | $14362 | $14344 | $15796 | $15769 |
| Current liabilities | ||||
| Accounts payable | $270 | $296 | $354 | $381 |
| Deferred revenue | ||||
| Short long term debt | $38 | $39 | $39 | $381 |
| Total current liabilities | $1241 | $1265 | $1284 | $1578 |
| Long term debt | $5736 | $5870 | $6023 | $5639 |
| Total noncurrent liabilities | $6898 | $6945 | $7092 | $6711 |
| Total debt | $5774 | $5909 | $6062 | $6020 |
| Total liabilities | $8139 | $8210 | $8376 | $8289 |
| Shareholders' equity | ||||
| Retained earnings | -$2288 | -$2147 | -$1051 | -$954 |
| Other shareholder equity | -$266 | -$482 | -$281 | -$310 |
| Total shareholder equity | $6223 | $6134 | $7420 | $7480 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $352 | $345 | $638 | $505.4 |
| Short term investments | ||||
| Net receivables | $1010 | $1002 | $1028 | $1076.7 |
| Inventory | $1735 | $1538 | $1373 | $1578.1 |
| Total current assets | $3407 | $3279 | $3276 | $3416.5 |
| Long term investments | $33.4 | |||
| Property, plant & equipment | $1026 | $1140 | $1061 | $1316.3 |
| Goodwill & intangible assets | $9588 | $10835 | $11759 | $12612.1 |
| Total noncurrent assets | $10955 | $12212 | $13207 | $14276.2 |
| Total investments | ||||
| Total assets | $14362 | $15491 | $16483 | $17692.7 |
| Current liabilities | ||||
| Accounts payable | $270 | $390 | $418 | $506 |
| Deferred revenue | ||||
| Short long term debt | $38 | $388 | $294 | $554.5 |
| Total current liabilities | $1241 | $1702 | $1643 | $2076.3 |
| Long term debt | $5736 | $5448 | $6025 | $5572.4 |
| Total noncurrent liabilities | $6898 | $6500 | $7302 | $7140.5 |
| Total debt | $5774 | $5836 | $6319 | $6126.9 |
| Total liabilities | $8139 | $8202 | $8945 | $9216.8 |
| Shareholders' equity | ||||
| Retained earnings | -$2288 | -$1057 | -$949 | -$477.2 |
| Other shareholder equity | -$266 | -$392 | -$209 | $303 |
| Total shareholder equity | $6223 | $7289 | $7538 | $8475.9 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1035 | $1068 | $1057 | $1257 |
| Cost of revenue | $516 | $487 | $434 | $494 |
| Gross Profit | $519 | $581 | $623 | $763 |
| Operating activities | ||||
| Research & development | $79 | $86 | $81 | $81 |
| Selling, general & administrative | $292 | $313 | $353 | $327 |
| Total operating expenses | $579 | $1606 | $628 | $591 |
| Operating income | -$60 | -$1025 | -$5 | $172 |
| Income from continuing operations | ||||
| EBIT | -$60 | -$1025 | -$5 | $172 |
| Income tax expense | $14 | -$1 | $18 | $5 |
| Interest expense | $67 | $72 | $74 | $64 |
| Net income | ||||
| Net income | -$141 | -$1096 | -$97 | $103 |
| Income (for common shares) | -$141 | -$1096 | -$97 | $103 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4417 | $4411 | $4765 | $3273.3 |
| Cost of revenue | $1931 | $1913 | $2134 | $1666.6 |
| Gross Profit | $2486 | $2498 | $2631 | $1606.7 |
| Operating activities | ||||
| Research & development | $327 | $321 | $369 | $327 |
| Selling, general & administrative | $1285 | $1265 | $1404 | $996.6 |
| Total operating expenses | $3404 | $2329 | $2962 | $2128.9 |
| Operating income | -$918 | $169 | -$331 | -$522.2 |
| Income from continuing operations | ||||
| EBIT | -$918 | $169 | -$331 | -$522.2 |
| Income tax expense | $36 | $6 | -$95 | -$111.9 |
| Interest expense | $277 | $241 | $236 | $149.8 |
| Net income | ||||
| Net income | -$1231 | -$78 | -$472 | -$560.1 |
| Income (for common shares) | -$1231 | -$78 | -$472 | -$560.1 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$141 | -$1096 | -$97 | $103 |
| Operating activities | ||||
| Depreciation | $171 | $173 | $177 | $173 |
| Business acquisitions & disposals | -$3 | -$16 | ||
| Stock-based compensation | $15 | $10 | $9 | $12 |
| Total cash flows from operations | $157 | $198 | $61 | -$145 |
| Investing activities | ||||
| Capital expenditures | -$41 | -$33 | -$42 | -$24 |
| Investments | ||||
| Total cash flows from investing | -$35 | -$36 | -$43 | -$55 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$139 | -$156 | $37 | $181 |
| Total cash flows from financing | -$139 | -$157 | $39 | $174 |
| Effect of exchange rate | -$3 | -$8 | -$1 | |
| Change in cash and equivalents | -$17 | $2 | $49 | -$27 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$1231 | -$78 | -$472 | -$560.1 |
| Operating activities | ||||
| Depreciation | $694 | $682 | $716 | $516.9 |
| Business acquisitions & disposals | -$19 | $13 | -$342 | -$4566.6 |
| Stock-based compensation | $46 | $59 | $66 | $47.7 |
| Total cash flows from operations | $271 | $452 | $483 | -$41 |
| Investing activities | ||||
| Capital expenditures | -$140 | -$171 | -$142 | -$238.2 |
| Investments | $32.7 | |||
| Total cash flows from investing | -$169 | -$179 | -$530 | -$4779.2 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1219.9 | |||
| Net borrowings | -$77 | -$533 | $239 | $3750.2 |
| Total cash flows from financing | -$83 | -$549 | $210 | $4953.9 |
| Effect of exchange rate | -$12 | -$17 | -$31 | $26.6 |
| Change in cash and equivalents | $7 | -$293 | $132 | $160.3 |
News
Fundamentals
| Market cap | $6.43B |
|---|---|
| Enterprise value | $11.85B |
| Shares outstanding | 492.85M |
| Revenue | $4.42B |
|---|---|
| EBITDA | -$224.00M |
| EBIT | -$918.00M |
| Net Income | -$1.23B |
| Revenue Q/Q | 5.50% |
| Revenue Y/Y | 0.14% |
| P/E ratio | -5.22 |
|---|---|
| EV/Sales | 2.68 |
| EV/EBITDA | -52.90 |
| EV/EBIT | -12.91 |
| P/S ratio | 1.45 |
| P/B ratio | 0.99 |
| Book/Share | 13.17 |
| Cash/Share | 0.71 |
| EPS | -$2.50 |
|---|---|
| ROA | -8.17% |
| ROE | -18.07% |
| Debt/Equity | 1.31 |
|---|---|
| Net debt/EBITDA | -34.76 |
| Current ratio | 2.75 |
| Quick ratio | 1.35 |